Dillon J. Wade MD , Collin Pilkington BS , J. Curran Henson MD, MS , Hanna K. Jensen MD, PhD , Kyle Kalkwarf MD , Avi Bhavaraju MD , Nolan Bruce MD , Stephen Bowman PhD , Joseph Margolick MD
{"title":"较高剂量的钙与创伤患者的存活率有关。","authors":"Dillon J. Wade MD , Collin Pilkington BS , J. Curran Henson MD, MS , Hanna K. Jensen MD, PhD , Kyle Kalkwarf MD , Avi Bhavaraju MD , Nolan Bruce MD , Stephen Bowman PhD , Joseph Margolick MD","doi":"10.1016/j.jss.2024.02.014","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div><span>Calcium is required for coagulation, cardiac output, and peripheral vascular resistance<span><span>. Between 85% and 94% of trauma patients treated with massive </span>blood transfusion develop hypocalcemia.</span></span><sup>1</sup> The aim of this study is to evaluate the relationship between increased intravenous calcium administration during massive transfusion and improved survival of trauma patients.</div></div><div><h3>Methods</h3><div><span>We performed a retrospective analysis of trauma patients who received massive transfusion over a 2-y period. Doses of elemental calcium administered per unit of blood product transfused were calculated by calcium to blood product ratio (CBR). Chi-square test evaluated association between coagulopathy and 30-d mortality. Two-sample </span><em>t</em><span><span>-test evaluated association between CBR and coagulopathy. Bivariate regression analysis evaluated association between CBR and blood products transfused per patient. Multivariable </span>logistic regression analysis<span>, controlling for age, sex, coagulopathy, and Injury Severity Score evaluated the association between CBR and mortality.</span></span></div></div><div><h3>Results</h3><div>The study included 77 patients. Coagulopathy was associated with increased 30-d mortality (<em>P</em> < 0.05). Patients who survived had higher CBR than those who died (<em>P</em> < 0.05). CBR was associated with a significant reduction in total blood products transfused per patient (<em>P</em> < 0.05). CBR was not associated with coagulopathy (<em>P</em> = 0.24). Multivariable logistic regression analysis demonstrated that Injury Severity Score ≥16, coagulopathy and decreased CBR were significant predictors of mortality (<em>P</em> < 0.05). CBR above 50 mg was a predictor of survival (<em>P</em> < 0.05).</div></div><div><h3>Conclusions</h3><div>Higher doses of calcium given per blood product transfused were associated with improved 30-d survival and decreased blood product transfusions.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"303 ","pages":"Pages 788-794"},"PeriodicalIF":1.8000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Higher Doses of Calcium Associated With Survival in Trauma Patients\",\"authors\":\"Dillon J. Wade MD , Collin Pilkington BS , J. Curran Henson MD, MS , Hanna K. Jensen MD, PhD , Kyle Kalkwarf MD , Avi Bhavaraju MD , Nolan Bruce MD , Stephen Bowman PhD , Joseph Margolick MD\",\"doi\":\"10.1016/j.jss.2024.02.014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div><span>Calcium is required for coagulation, cardiac output, and peripheral vascular resistance<span><span>. Between 85% and 94% of trauma patients treated with massive </span>blood transfusion develop hypocalcemia.</span></span><sup>1</sup> The aim of this study is to evaluate the relationship between increased intravenous calcium administration during massive transfusion and improved survival of trauma patients.</div></div><div><h3>Methods</h3><div><span>We performed a retrospective analysis of trauma patients who received massive transfusion over a 2-y period. Doses of elemental calcium administered per unit of blood product transfused were calculated by calcium to blood product ratio (CBR). Chi-square test evaluated association between coagulopathy and 30-d mortality. Two-sample </span><em>t</em><span><span>-test evaluated association between CBR and coagulopathy. Bivariate regression analysis evaluated association between CBR and blood products transfused per patient. Multivariable </span>logistic regression analysis<span>, controlling for age, sex, coagulopathy, and Injury Severity Score evaluated the association between CBR and mortality.</span></span></div></div><div><h3>Results</h3><div>The study included 77 patients. Coagulopathy was associated with increased 30-d mortality (<em>P</em> < 0.05). Patients who survived had higher CBR than those who died (<em>P</em> < 0.05). CBR was associated with a significant reduction in total blood products transfused per patient (<em>P</em> < 0.05). CBR was not associated with coagulopathy (<em>P</em> = 0.24). Multivariable logistic regression analysis demonstrated that Injury Severity Score ≥16, coagulopathy and decreased CBR were significant predictors of mortality (<em>P</em> < 0.05). CBR above 50 mg was a predictor of survival (<em>P</em> < 0.05).</div></div><div><h3>Conclusions</h3><div>Higher doses of calcium given per blood product transfused were associated with improved 30-d survival and decreased blood product transfusions.</div></div>\",\"PeriodicalId\":17030,\"journal\":{\"name\":\"Journal of Surgical Research\",\"volume\":\"303 \",\"pages\":\"Pages 788-794\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Surgical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0022480424000945\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Surgical Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022480424000945","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
Higher Doses of Calcium Associated With Survival in Trauma Patients
Introduction
Calcium is required for coagulation, cardiac output, and peripheral vascular resistance. Between 85% and 94% of trauma patients treated with massive blood transfusion develop hypocalcemia.1 The aim of this study is to evaluate the relationship between increased intravenous calcium administration during massive transfusion and improved survival of trauma patients.
Methods
We performed a retrospective analysis of trauma patients who received massive transfusion over a 2-y period. Doses of elemental calcium administered per unit of blood product transfused were calculated by calcium to blood product ratio (CBR). Chi-square test evaluated association between coagulopathy and 30-d mortality. Two-sample t-test evaluated association between CBR and coagulopathy. Bivariate regression analysis evaluated association between CBR and blood products transfused per patient. Multivariable logistic regression analysis, controlling for age, sex, coagulopathy, and Injury Severity Score evaluated the association between CBR and mortality.
Results
The study included 77 patients. Coagulopathy was associated with increased 30-d mortality (P < 0.05). Patients who survived had higher CBR than those who died (P < 0.05). CBR was associated with a significant reduction in total blood products transfused per patient (P < 0.05). CBR was not associated with coagulopathy (P = 0.24). Multivariable logistic regression analysis demonstrated that Injury Severity Score ≥16, coagulopathy and decreased CBR were significant predictors of mortality (P < 0.05). CBR above 50 mg was a predictor of survival (P < 0.05).
Conclusions
Higher doses of calcium given per blood product transfused were associated with improved 30-d survival and decreased blood product transfusions.
期刊介绍:
The Journal of Surgical Research: Clinical and Laboratory Investigation publishes original articles concerned with clinical and laboratory investigations relevant to surgical practice and teaching. The journal emphasizes reports of clinical investigations or fundamental research bearing directly on surgical management that will be of general interest to a broad range of surgeons and surgical researchers. The articles presented need not have been the products of surgeons or of surgical laboratories.
The Journal of Surgical Research also features review articles and special articles relating to educational, research, or social issues of interest to the academic surgical community.